American Woman Stunned After Finding $900 Cancer Drug Selling for Just 37 Cents in India

A viral video has reignited one of the biggest debates surrounding healthcare after an American woman claimed she discovered that a life-saving cancer medication costing around $900 per pill in the United States is available in India for as little as 37 cents. Her emotional reaction quickly struck a nerve online, with millions of viewers questioning why patients can face such wildly different prices for the same treatment depending on where they live.

The woman, who posts on Instagram under the name Spicy Gori, shared the discovery after looking into the price of Revlimid, a medication used to treat certain types of blood cancer. While researching treatment costs for someone she identified as Mayan, she found that the drug carried a staggering price tag in the U.S. Yet the same medicine appeared to be available from Indian manufacturers for a tiny fraction of that cost. Calling the difference “robbery,” she sparked a conversation that has since expanded far beyond social media, drawing attention to prescription drug pricing, generic medicines, and the growing frustration many patients feel over the cost of staying alive.

View this post on Instagram

A post shared by Liz & Shiv (@lizandshiv)

A Simple Search Led to a Stunning Discovery

In the now-viral clip, the American influencer explained that she had been trying to understand how expensive cancer treatment could become for patients in the United States. During her search, she came across Revlimid, a medication commonly prescribed for blood cancers such as multiple myeloma, and was immediately shocked by the listed price. According to her, a single capsule could cost around $900, a figure that quickly adds up for patients who require the medication over extended periods.

Curious whether those prices were similar elsewhere, she decided to check what patients in India were paying. What she found completely changed the conversation. Indian listings showed the medication selling for anywhere between Rs 35 and Rs 300 per pill, roughly equivalent to $0.37 to $3, depending on the manufacturer and supplier. The difference was so dramatic that she questioned how both prices could exist for what appeared to be the same treatment.

Reacting to the discovery, she told viewers that Americans were “being robbed,” arguing that the comparison exposed just how expensive healthcare has become in the United States. Her comments resonated with many viewers who have struggled with prescription drug costs themselves, helping the video spread rapidly across Instagram and other social media platforms.

The comparison also highlighted a broader issue that extends well beyond a single medication. Around the world, patients often pay vastly different prices for identical drugs because of national healthcare systems, patent laws, insurance structures, and the availability of generic alternatives. Revlimid simply became the latest example to capture public attention.

Millions Joined the Conversation Online

The video quickly attracted millions of views, with thousands of people sharing their own experiences of paying for prescription medicines. Many commenters said they were not surprised by the enormous difference, arguing that Americans have long faced some of the highest drug prices anywhere in the world. Others described the comparison as one of the clearest examples yet of how healthcare costs can vary dramatically across borders.

Several users praised India’s pharmaceutical industry, pointing out that the country has become one of the world’s leading producers of affordable generic medicines. They argued that competition between manufacturers has helped make many essential drugs accessible not only for Indian patients but also for people across dozens of other countries that rely on Indian pharmaceutical exports.

Others shared personal stories of purchasing medications during trips to India because they found them significantly cheaper than prices in both the United States and parts of Europe. Some even said friends and relatives regularly compare international prices before filling prescriptions, particularly when dealing with long-term medical conditions that require ongoing treatment.

Not every comment was entirely supportive of the comparison, however. Some users pointed out that medication prices vary depending on the manufacturer, the healthcare provider, and whether a patient qualifies for government assistance or insurance benefits. Others noted that while medicines may be cheaper in India, access to healthcare can still differ depending on a person’s financial circumstances and where they receive treatment.

Why The Same Drug Can Cost Hundreds More In America

At the heart of the debate is the way prescription medicines are priced in different countries. In the United States, pharmaceutical companies typically enjoy strong patent protections that allow brand-name manufacturers to sell medicines without direct competition for years. During that period, companies often argue that higher prices help recover the billions of dollars invested in research, clinical trials, and regulatory approval before a drug ever reaches patients.

Unlike many other countries, the United States also has relatively limited government control over prescription drug pricing. Instead, manufacturers, insurance companies, pharmacy benefit managers, and healthcare providers all play a role in determining how much patients ultimately pay. While insured individuals may receive discounted prices through negotiated agreements, those without adequate coverage can face much higher out-of-pocket costs.

Healthcare experts have debated this system for years. Supporters argue that pharmaceutical innovation depends on companies being able to recover research costs and invest in developing future treatments. Critics counter that the current model places an enormous financial burden on patients who often have little choice but to pay whatever price is required for medicines they need to survive.

Revlimid has become one of the most visible examples of that debate because its price difference is so easy to understand. When people see one pill selling for hundreds of dollars in one country and less than a dollar in another, it naturally raises difficult questions about how prescription medicines are valued and who ultimately bears the cost.

Why India Can Sell The Drug For A Fraction Of The Price

One of the biggest reasons behind the dramatic price difference is India’s enormous generic pharmaceutical industry. Over the past several decades, the country has become one of the world’s largest producers of generic medicines, supplying affordable drugs to patients in more than 200 countries. Once patents expire or local regulations allow, multiple manufacturers can produce equivalent versions of many medications, creating competition that naturally pushes prices lower.

Unlike brand-name drugs sold under exclusive patents, generic medicines contain the same active ingredients and are required to meet quality and safety standards before they reach patients. Because manufacturers do not have to repeat years of expensive research and clinical development, they are often able to produce the same treatment at a much lower cost. Competition between dozens of companies further reduces prices, benefiting both domestic patients and healthcare systems abroad.

Government policies also play a significant role. India has introduced various measures over the years aimed at improving access to essential medicines, while many public hospitals provide subsidized or free treatment for eligible patients suffering from serious illnesses, including certain cancers. Although affordability still depends on the medication and healthcare provider, these policies have helped millions gain access to treatments that might otherwise remain out of reach.

Experts say the comparison highlighted in the viral video reflects the differences between two very different healthcare systems rather than a problem with the medicine itself. Pricing is influenced by patent rules, manufacturing costs, government regulation, market competition, and insurance structures, all of which vary widely from one country to another.

Factors Behind India’s Lower Drug Prices

Several key factors contribute to why medicines often cost far less in India than they do in the United States:

• A strong generic pharmaceutical industry that produces affordable alternatives after patents allow competition.
• Competition between manufacturers, which helps drive prices down.
• Government oversight on the pricing of many essential medicines.
• Lower manufacturing and operating costs compared with many Western countries.
• Large-scale domestic production, reducing dependence on imported pharmaceuticals.

Together, these factors have made India one of the world’s largest suppliers of affordable medicines, with many countries relying on Indian pharmaceutical companies to help meet healthcare needs.

The Viral Debate Has Reopened Questions About Healthcare Costs

Although the video focused on a single cancer medication, many viewers felt it reflected a much larger problem. Prescription drug prices have become one of the most controversial aspects of the American healthcare system, particularly for patients managing chronic illnesses that require continuous treatment. Even with insurance, many families still face significant out-of-pocket expenses, while those without adequate coverage can struggle to afford medicines prescribed by their doctors.

Healthcare experts have argued for years that the United States pays considerably more for many prescription drugs than other developed countries. Supporters of the current system often point to the enormous costs involved in developing new medicines, saying pharmaceutical companies need strong financial returns to continue investing in research. Critics, however, argue that patients should not have to choose between paying their bills and accessing life-saving treatment.

The discussion has become even more relevant as more patients compare international prices online. Some Americans legally explore purchasing medications abroad where regulations permit, while others simply question why identical treatments can cost so much less elsewhere. Social media has made those comparisons easier than ever, bringing pricing differences into public view and fueling renewed calls for reform.

At the same time, experts caution against oversimplifying the issue. Drug prices can vary depending on insurance coverage, local regulations, manufacturers, and healthcare providers. They also note that not every medication available in one country can be legally imported into another, making it important for patients to seek medical advice before changing treatment plans.

One Viral Video Sparked A Conversation That Won’t Disappear

The woman behind the viral post may have only intended to highlight a surprising price difference, but her discovery quickly evolved into a global discussion about fairness, affordability, and access to healthcare. For millions of viewers, the comparison between a $900 cancer pill in the United States and one costing less than a dollar in India illustrated just how differently healthcare systems can affect the lives of ordinary people.

Whether the debate ultimately leads to policy changes remains to be seen. What is already clear is that the enormous gap in prescription drug prices has become impossible for many people to ignore. As more patients compare costs across borders and share their experiences online, pressure is likely to continue growing on lawmakers, healthcare providers, and pharmaceutical companies to explain why life-saving medicines remain so expensive for so many Americans.